Heart health: Stanford University maps rare mRNA vaccine–linked myocarditis pathway, flags soy compound as potential risk mitigator

Heart health: Stanford University maps rare mRNA vaccine–linked myocarditis pathway, flags soy compound as potential risk mitigator

January 02, 2026
Stanford researchers identified a two-step immune process causing rare myocarditis after mRNA COVID-19 vaccines, primarily in young males. This involves macrophages releasing CXCL10, which summons T cells to produce IFN-gamma, leading to heart inflammation. Natural soy compound genistein showed promise in mitigating this inflammatory response.

from LifeStyle - Latest Lifestyle News, Hot Trends, Celebrity Styles & Events https://ift.tt/fICenj0
https://ift.tt/BoCIWTH
Next
« Prev Post
Previous
Next Post »
Subscribe to: Post Comments (Atom)

Neurologist shares 3 new year resolutions for better brain health in 2026​

With the beginning of a new year, many of us prioritize physical health as one of our resolutions. However, our modern-day lifestyle demands...